Lenalidomide treatment in relapsed/refractory B-cell lymphomas: A single center real-life experience
As an immunomodulatory drug, lenalidomide has been shown to have anti-lymphoma activity and is used in combination with several agents in the treatment of patients with relapsed/refractory disease. In this study, we aimed to evaluate the efficiency of lenalidomide in the treatment of B-cell NHL. Thi...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Society of Turaz Bilim
2022-06-01
|
| Серии: | Medicine Science |
| Предметы: | |
| Online-ссылка: | http://www.ejmanager.com/fulltextpdf.php?mno=12001 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|